European Commission wants hazardous substances law to cover devices
This article was originally published in RAJ Devices
Executive Summary
The European Commission has proposed that medical devices and instruments used for monitoring and control generally be no longer exempt from the scope of the European directive on the restriction of hazardous substances in electrical and electronic equipment1,2. It has also proposed priority assessment of four new substances, namely the phthalates DEHP, DBP and BBP, and the flame retardant HBCDD, with a view to possibly banning their use in the future.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.